Patents Assigned to Roche Diagnostics Operations, Inc.
  • Publication number: 20210174943
    Abstract: A method for tracking availability of a point-of-care (POC) device for a user is provided. The method comprises entering type(s) of test(s) needed by the user, providing a list of available POC devices to the user based on the type(s) of test(s) needed, based on the list of available POC devices, providing a map to the user showing locations of nearby POC devices with availability for the type(s) of test(s) needed; selecting one of the nearby POC devices by touching the location of the POC device on the map and booking that POC device for the type(s) of test(s) needed at a particular time slot, and communicating the booking to the selected POC device. The selected POC device then blocks that time slot.
    Type: Application
    Filed: December 2, 2020
    Publication date: June 10, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Fernando Blanco
  • Publication number: 20210173769
    Abstract: A laboratory system is disclosed. The laboratory system comprises a plurality of laboratories comprising one or more analytical instruments for performing a plurality of analytical tests (T1-n) and providing analytical test results (TR1-n) and a remote computer communicatively connected to the laboratories. Each of the laboratories is configured to define test result validation criteria (C1-n) for validating at least one of the analytical test results (TR1-n) associated with the respective analytical tests (T1-n) of one of the plurality of laboratories. The remote computer is configured to define a plurality of profiles (P1-n) of validation criteria, to assign the profiles (P1-n) of test result validation criteria (C1-n) to one or more of the laboratories (102), and to perform an automatic validation of groups (G1-n) of the analytical test results (TR1-n) according to the profiles (P1-n) of test result validation criteria (C1-n).
    Type: Application
    Filed: February 18, 2021
    Publication date: June 10, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Albert Puig
  • Publication number: 20210172725
    Abstract: A method for determining a vertical position of a horizontally extending interface between first and second components is presented. The first and second components are contained in a laboratory sample container in layers vertically separated from each other. The method comprises generating first data, generating second data in the form of picture data of the laboratory sample container containing the first and second components, determining a first probability distribution function in response to the first data, determining a second probability distribution function in response to the second data, and determining the vertical position of the horizontally extending interface depending on the first and second probability distribution functions. The first data depend on the vertical position of the horizontally extending interface. The first and second probability distribution functions assign a probability of the presence of the horizontally extending interface to a vertical position.
    Type: Application
    Filed: December 3, 2020
    Publication date: June 10, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventor: Michael Rein
  • Publication number: 20210170390
    Abstract: An in-vitro diagnostic device including a pipetting unit and a pipetting method, which allow for a more reproducible and more precise pipetting of liquids, when piercing through a lid of a closed liquid container is required. The pipetting unit is controlled to repeat penetration of the lid of the closed liquid container if the pressure difference between the interior of the liquid container and the surrounding is outside an allowable predefined pressure range.
    Type: Application
    Filed: November 17, 2020
    Publication date: June 10, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Ronald Egli, Mirko Klingauf, Daniel Ott, Jerome Wiss
  • Publication number: 20210164969
    Abstract: Methods and systems for diagnosing functional and/or structural abnormalities of the heart preceding heart failure, and for predicting the risk of developing heart failure, in a subject comprising measuring a cardiac troponin in a sample and comparing the measurement to a reference value. Other markers, including GDF15 and IGFBP7 are also measured in some embodiments.
    Type: Application
    Filed: January 29, 2021
    Publication date: June 3, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Ursula-Henrike Wienhues-Thelen, Dirk Block, Hendrik Heudig, Sabine Vogel-Ziebolz, Christine Boehm, Georg Hess, Andrea Horsch, Dietmar Zdunek
  • Publication number: 20210168124
    Abstract: A method for processing data of an analytical instrument for analyzing biological samples is presented. The method comprises receiving instrument data from the analytical instrument at a data processing module communicatively connected with the analytical instrument, generating metadata from the received instrument data at the data processing module, applying a first encryption to the instrument data at the data processing module, applying a second encryption to the generated metadata at the data processing module, and transmitting the encrypted metadata and encrypted instrument data to a remote server. The remote server and the data processing module are communicatively connected. The method also comprises removing the second encryption from the metadata at the remote server and forwarding the instrument data encrypted by the first encryption from the remote server to a management system of the analytical instrument.
    Type: Application
    Filed: January 19, 2021
    Publication date: June 3, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Urs Suter, Alejandro Morcillo Montejo, Antonio Tienda Fernandez, Stephen Martin
  • Patent number: 11021472
    Abstract: The present invention relates to the use compounds comprising two or more hydrophobic domains and a hydrophilic domain comprising a polyethylene glycol (PEG) moiety for stabilization of a cell, and methods related thereto.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: June 1, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Hans-Peter Josel, Dieter Heindl, Thomas Froehlich, Stefanie Froehner
  • Publication number: 20210154684
    Abstract: A bucket insert for use in a centrifuge is disclosed. The bucket insert comprises an insert body, the insert body comprising a plurality of elongated receptacles for receiving elongated sample vessels. The bucket insert is configured for orienting the elongated sample vessels in a tilted orientation. In the tilted orientation, at least some of the elongated sample vessels are oriented in a non-parallel fashion.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 27, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Claudio Cherubini, Andreas Drechsler
  • Publication number: 20210156875
    Abstract: The present invention relates to a method for assessing atrial fibrillation in a subject, said method comprising the steps of determining the amount of DKK3 in a sample from the subject, and comparing the amount of DKK3 to a reference amount, whereby atrial fibrillation is to be assessed. Moreover, the present invention relates to a method for diagnosing heart failure and/or at least one structural or functional abnormality of the heart associated with heart failure.
    Type: Application
    Filed: January 29, 2021
    Publication date: May 27, 2021
    Applicants: Roche Diagnostics Operations, Inc., Universitaet Maastricht, Academisch Ziekenhuis Maastricht
    Inventors: Johann Karl, Peter Kastner, Roberto Latini, Vinzent Rolny, Ursula-Henrike Wienhues-Thelen, Andre Ziegler, Manuel Dietrich, Jennifer Meessen, Ulrich Schotten
  • Patent number: 11016102
    Abstract: Method for determination of whether a subject suffers from intermittent atrial fibrillation based on the determination of the amount of a Troponin T in a sample in a patient suffering from atrial fibrillation using a binding assay. Kits and devices adapted to carry out the methods are also provided.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: May 25, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Georg Hess, Andrea Horsch, Dietmar Zdunek
  • Patent number: 11016098
    Abstract: A method and an apparatus for determining a concentration of a target analyte in a sample of bodily fluid are disclosed. The method involves providing a sample of bodily fluid including the target analyte, providing an internal standard solution including a mixture of components having a plurality of isotopes of the target analyte, wherein a concentration of each isotope is unknown, adding the internal standard solution to the sample, analyzing the sample including the internal standard solution using a mass spectrometer, creating a sample function curve based on signal intensities, wherein the signal intensities define arbitrary units, transferring an analyte signal into a corresponding arbitrary analyte unit by means of the sample function curve, and transferring the arbitrary analyte unit into the concentration of a target analyte by means of a standardization function representing a curve of concentrations depending on the arbitrary units.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: May 25, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Uwe Kobold, Roland Thiele, Noah Weiss, Benjamin Tiemann
  • Publication number: 20210146368
    Abstract: An apparatus for determining properties of a laboratory sample container is presented. The apparatus comprises a light source for emitting light to illuminate the laboratory sample container and a number of curved reflecting and/or scattering units. A respective curved reflecting and/or scattering unit comprises a curved shape and is adapted to reflect and/or scatter light of the light source to an outer surface of the laboratory sample container for illuminating the laboratory sample container. The apparatus also comprises a camera adapted to take an image of the laboratory sample container. The image comprises image data related to the laboratory sample container. The apparatus also comprises a control unit adapted to determine the properties of the laboratory sample container based on the image data related to the laboratory sample container.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Michael Rein, Benjamin Sauer
  • Patent number: 11009499
    Abstract: A method for determining properties of a laboratory sample contained in a laboratory sample container is presented. The method comprises measuring projections of the laboratory sample container comprising the laboratory sample by irradiating light to the laboratory sample container at different projection angle and determining the properties by tomographic reconstruction based on the projections.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: May 18, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Michael Rein
  • Publication number: 20210140987
    Abstract: A method for operating a laboratory system comprising instruments for processing samples and a control unit connected by a communication network is presented. The method comprises receiving and identifying a biological sample and retrieving an order list from a database. The list comprises a plurality of targets defining one or more processing steps to be carried out on the biological sample by one or more of the laboratory instruments. The method also comprises selecting a workflow strategy and retrieving workflow acceptance criterion corresponding to the workflow strategy. The control unit determines a sample workflow for processing the sample based on the workflow strategy and determines whether the sample workflow satisfies the workflow acceptance criterion. If the sample workflow does not satisfy the workflow acceptance criterion, workflow strategy and the workflow acceptance criterion is refined and the sample workflow is determined again until it satisfies the workflow acceptance criterion.
    Type: Application
    Filed: December 14, 2020
    Publication date: May 13, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Marco Maetzler, Christopher Schofield, Ole Lambaek, Moritz von Hopffgarten
  • Patent number: 11002726
    Abstract: A test element analysis system for an analytical examination of a sample, in particular of a body fluid, is disclosed. The test element analysis system comprises an evaluation device with a test element holder for positioning a test element containing the sample and a measuring device for measuring a change in a measuring zone of the test element, the change being characteristic for an analyte. The test element holder contains contact elements with contact surfaces which allow an electrical contact between contact surfaces of the test element and the contact surfaces of the test element holder. The contact surfaces of the contact elements of the test element holder are provided with an electrically conductive surface containing metallic ruthenium.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: May 11, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Kai Hebestreit, Sylvia Saecker, Klaus Thome, Werner Heidt
  • Patent number: 11002749
    Abstract: A computer-implemented method of calibrating an in-vitro diagnostic analyzer is disclosed. The method includes executing a multi-point calibration procedure including measuring a plurality of calibrator levels and thereby obtaining a plurality of respective calibration points. The method further includes calculating a result of the multi-point calibration procedure and determining failure or passing of the multi-point calibration procedure based on the calculated result. In case of failure of the multi-point calibration procedure, the method includes determining if failure is related to one or more individual failed calibration point(s), and in the affirmative, triggering a repetition of measuring the calibrator level(s) only with respect to the failed calibration point(s) and re-calculating the result of the multi-point calibration procedure after replacing only the failed calibration point(s) with the newly obtained calibration point(s).
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: May 11, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Mirko Klingauf
  • Patent number: 11001602
    Abstract: The present disclosure relates to photoactivable protecting groups containing a diarylsulfide chromophore, a method for the synthesis thereof and their use as photoactivable protecting groups using maskless photolithography based array synthesis.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: May 11, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Klaus-Peter Stengele
  • Patent number: 11000848
    Abstract: A medical system for determining an analyte quantity in a blood sample via a cartridge that spins around a rotational axis. The cartridge may include: a separation chamber that separates blood plasma from the sample; a processing chamber containing a reagent with a specific binding partner which binds to the analyte to form an analyte specific binding partner complex; a first valve structure connecting the separation chamber to the processing chamber; a measurement structure to measure the quantity of the analyte, wherein the measurement structure includes a chromatographic membrane with an immobilized binding partner for direct or indirect binding of the analyte or the analyte specific binding partner complex, and an absorbent structure that is nearer to the axis than the membrane; a second valve structure connecting the processing chamber to the measurement structure; and a fluid chamber filled with a washing buffer and fluidically connected to the measurement structure.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: May 11, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Christoph Boehm, Thomas Dolbinow, Sabrina Adler, Erik Beiersdorf, Domenik Wensorra, Thorsten Brueckner, Thomas Fischer, Eloisa Lopez-Calle, Sascha Lutz, Josef Roedl, Juergen Spinke, Pamela Espindola, Thomas Manuel Keller
  • Publication number: 20210132093
    Abstract: A method of operating an analytical laboratory is presented. The method comprises the steps of: setting a load limit for each laboratory instrument at maximum instrument capacity; dispatching biological samples to laboratory instrument(s) at a dispatch rate not greater than the instrument load limit; each laboratory instrument sending test order queries to the laboratory middleware upon identifying a biological sample; in response to the test order queries transmitting test orders to the laboratory instruments corresponding to the biological samples; the laboratory middleware monitoring a query rate of the plurality of laboratory instruments in order to determine an effective flow rate corresponding to each laboratory instrument; decreasing the load limit of a first laboratory instrument if its effective flow rate is lower than the dispatch rate; increasing the load limit for the first laboratory instrument if its effective flow rate is greater than or equal to the dispatch rate.
    Type: Application
    Filed: October 28, 2020
    Publication date: May 6, 2021
    Applicant: Roche Diagnostics Operations, Inc.
    Inventors: Frederic Furrer, Marco Maetzler
  • Patent number: 10996229
    Abstract: Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker IGFBP-7, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for IGFBP-7 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of IGFBP-7 as a marker protein in the assessment of heart failure, a marker combination comprising IGFBP-7 and a kit for measuring IGFBP-7.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: May 4, 2021
    Assignees: Roche Diagnostics Operations, Inc., The Governing Council of the University of Toronto
    Inventors: Ursula-Henrike Wienhues-Thelen, Georg Hess, Hendrik Huedig, Herbert von der Eltz, Andrew Emili, Anthony Gramolini, Peter Liu, David MacLennan, Vincent Fong, Ruth Isserlin, Thomas Kislinger, Dirk Block